Cardiome Pharma Corp.
Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.
Cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ Global Market (CRME).
Webcasts |
Recent Press Releases |
|
No current webcasts. MORE... |
Investigational BRINAVESS™ (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation MORE... Cardiome to Present at Wells Fargo Securities 2010 Healthcare Conference MORE... |
Disclaimer:
©2007 Stockgroup. Stockgroup Disclaimer. Quotes are provided by ComStock, Inc, a division of Interactive Data Corp. and are subject to their terms of use. Corporate and Financial Data is provided by CoreData. Data and information is provided for informational purposes only, and is not intended for trading purposes. Stockgroup shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Data is delayed 20 minutes for NYSE & AMEX and delayed 15 minutes for all other exchanges.